entrails again on that. It makes perfect sense why Shaxon isn't with ENR# any longer and why it is unlikely Dabney will pop up there. It is possible. but not likely since ENR# announced a week or two ago that the company was significantly scaling back their industry exposure in favor of the vaginal lubricant business. Yeah, I know, go figure, but they blame it on the mess that is MMPR
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.